Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
| no clinical added value |
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients. |
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
BVzm70SGueymBD9g
Listen
